SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-095588
Filing Date
2020-08-14
Accepted
2020-08-14 16:34:51
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2027343d1_s3.htm S-3 201748
2 EXHIBIT 5.1 tm2027343d1_ex5-1.htm EX-5.1 9400
3 EXHIBIT 23.1 tm2027343d1_ex23-1.htm EX-23.1 2351
4 GRAPHIC image_001.jpg GRAPHIC 2455
5 GRAPHIC image_002.jpg GRAPHIC 8607
6 GRAPHIC image_003.jpg GRAPHIC 11172
  Complete submission text file 0001104659-20-095588.txt   245816
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-246333 | Film No.: 201105700
SIC: 2834 Pharmaceutical Preparations